2 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow ANNA FALANGA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperimmune Plasma for Patients With COVID-19 treated with hyperimmune plasma - Covid19 | Not applicable | Unknown | ANNA FALANGA | 100 | 2020-07-02 | 2020-11-03 |
| Hemostatic Profile in Patients Affected by COVID-19 Observational study - Covid19, Thrombosis | Unknown | ANNA FALANGA | 400 | 2020-03-25 | 2020-10-20 |
COVID-19 (2) · Thrombosis (1)
COVID-19 Serotherapy (1) · Observation (1) · Therapeutics (1)
Italy (2)